Form 8-K - Current report:
SEC Accession No. 0001193125-25-122800
Filing Date
2025-05-20
Accepted
2025-05-20 06:44:43
Documents
14
Period of Report
2025-05-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d942089d8k.htm   iXBRL 8-K 32244
2 EX-10.1 d942089dex101.htm EX-10.1 134021
6 GRAPHIC g942089dsp02.jpg GRAPHIC 3519
  Complete submission text file 0001193125-25-122800.txt   322594

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sdgr-20250516.xsd EX-101.SCH 2863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdgr-20250516_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdgr-20250516_pre.xml EX-101.PRE 11270
17 EXTRACTED XBRL INSTANCE DOCUMENT d942089d8k_htm.xml XML 3662
Mailing Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036
Business Address 1540 BROADWAY 24TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

EIN.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39206 | Film No.: 25966115
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)